Nanomedicine

Our Core Value is service to the community: We do the best we can to try to contribute advances against disease. Thus, the Mission of the Nanomedicine Center at IMM is to bring nanotechnologies to the clinic. 

Our Medical Focus Areas are: Cancer; Cardiovascular Medicine; Infectious Diseases; Diabetes, but we gladly explore collaborative opportunities in other fields of medicine.

Our main Strategic Emphasis sectors are: Early Detection of Disease from Blood Proteomic Signatures; Injectable NanoVectors for Directed (Targeted/personalized) Therapeutics; and the Intelligent Implants for Controlled Time Release of Therapy

The Center’s Fundamental Platforms: Silicon/Semiconductors Nano/Microfabrication; Mathematics; Molecular Medicine; and the Pharmaceutical Sciences. We are an extremely diverse, multidisciplinary group that cherishes our mutual inter-dependence from the expertise of others. We firmly believe that the interfaces among disciplines are uncharted territories that are extraordinarily fertile ground for scientific breakthroughs. Research philosophy-wise, we tend to “swing for the fences” more often than not.   

Mauro Ferrari is Director of the Nanomedicine Center, Professor in the Brown Institute for Molecular Medicine (IMM), Professor on Internal Medicine (Cardiology) and Chairman of the Department of Biomedical Engineering at the University of Texas Health Science Center in Houston (UTHSC); Professor of Experimental Therapeutics at M.D. Anderson Cancer Center (MDA), Professor of Bioengineering at Rice University, and Professor of Cell and Molecular Biology at the University of Texas Medical Branch . He is President of the Alliance for Nanohealth, which comprises UTHSC, MDA, Rice, Baylor College of Medicine, Texas A&M Health Science Center, the University of Houston and the University of Texas Medical Branch.

Our Principal Funding sources are the National Cancer Institute, National Institutes of Health, NASA, the Department of Defense (TATRC), National Science Foundation, and the State of Texas Emerging Technology Fund.  We currently have about $ 12 Million in research funds.